Eloralintide vs GLP

[BreakinGenetics]

quote on quote

Eloralintide / LY3841136 is Eli Lilly’s experimental once-weekly injectable weight-loss drug. It is not a GLP-1 like Ozempic or tirzepatide. It is a selective amylin receptor agonist, meaning it mimics amylin signaling to increase fullness/satiety and reduce calorie intake. Lilly says it is still investigational, not an approved prescription product yet. (Lilly)

In a Phase 2 obesity trial, people on eloralintide reportedly lost about 9% to 20% body weight over 48 weeks, compared with about 0.4% on placebo. Lilly is also studying it with tirzepatide for obesity/overweight, including in people with type 2 diabetes. (Medical News Today)

Plain English: it’s Lilly’s answer to cagrilintide/petrelintide-style amylin drugs — appetite control, fullness, weight loss, potentially less nausea than GLP-1s, but it’s still in trials. Not something to buy as a research peptide or random vial; legit access would be through clinical trials or future approval.

 

[throwawayal]

This feels like chat GPT slop. Is there a point to this?

 

[NeonCypher]

Seems the largest complaint so far...

Again infancy stage, is extremely lethargy, fatigue and it's reported as being pretty rough, like waking up and going straight back to sleep for hours.

 

[micro2000]

Cagrilintide is already available and can be used with the GLPs. It works at low doses and does increase their effect.

 

[BreakinGenetics]

This feels like chat GPT slop. Is there a point to this?

Knowledge is power stupid write me a dear John in calligraphy how genuine and authentic it will be. Please include bibliography. Lmfao did your mother have any other children that survived?

 

[throwawayal]

Knowledge is power stupid write me a dear John in calligraphy how genuine and authentic it will be. Please include bibliography. Lmfao did your mother have any other children that survived?

You could have just said that there was no point to your AI slop. Instead you posted whatever this is.

 

[BreakinGenetics]

Shut up and learn bro. Dumbass. Who gives a F where info is sourced are you ready to learn or NO. Its not rocket science fool or you can stay a caveman

 

[throwawayal]

Shut up and learn bro. Dumbass

At least you can call me names without Chat GPT.

 

[BreakinGenetics]

Get a life

 

[TyLu]

quote on quote

Eloralintide / LY3841136 is Eli Lilly’s experimental once-weekly injectable weight-loss drug. It is not a GLP-1 like Ozempic or tirzepatide. It is a selective amylin receptor agonist, meaning it mimics amylin signaling to increase fullness/satiety and reduce calorie intake. Lilly says it is still investigational, not an approved prescription product yet. (Lilly)

In a Phase 2 obesity trial, people on eloralintide reportedly lost about 9% to 20% body weight over 48 weeks, compared with about 0.4% on placebo. Lilly is also studying it with tirzepatide for obesity/overweight, including in people with type 2 diabetes. (Medical News Today)

Plain English: it’s Lilly’s answer to cagrilintide/petrelintide-style amylin drugs — appetite control, fullness, weight loss, potentially less nausea than GLP-1s, but it’s still in trials. Not something to buy as a research peptide or random vial; legit access would be through clinical trials or future approval.

Eloralintide sounds good.
However, the current prices and the dosages offered aren't worth it yet.